Women's Day Advocacy Activity: Prevention Research and Pregnant Populations: A plan for action
Prevention Research and Pregnant Populations: A plan for action
March 7, 2023
Dear Advocate,
International Women’s Day is on March 8 and
its 2023 #EmbraceEquity campaign put the question of justice and inclusion
first and foremost. AVAC is right there to champion the call. At the
just-concluded Conference on Retroviruses and Opportunistic Infections (CROI),
the sessions were filled with data showing the urgency to meet the needs of
women and gender diverse populations for their health and wellness. See our
CROI round-up, especially the section Women and Choice: The data say yes!
While incidence of HIV and other health
threats, social and economic barriers, and gender-based violence have
destructive effects on women around the world, research is making strides in
developing interventions that can and should offer women powerful choices for
HIV prevention and the protection of their overall health (be sure to check out
the updates from the DELIVER and B-Protected studies!). But critical gaps
remain.
Pregnancy and the post-partum period are times
of heightened HIV risk. Cisgender women are two to three times more likely to
acquire HIV during pregnancy per exposure and four times more likely
post-partum than otherwise. People who acquire HIV during pregnancy have an 18
percent chance of transmitting HIV to their newborn, which goes up to a 27
percent chance if they acquire HIV while breastfeeding.
Yet, HIV prevention options for pregnant and
breastfeeding/lactating people and populations (PLP) are limited, and their
inclusion in research inadequate—hence evidence gaps can be seen across the
research landscape for new prevention products.
The Coalition to Accelerate and Support
Prevention Research (CASPR), AVAC and partners are proud to jointly release
with PHASES, our latest effort to take aim at one of these gaps and close them.
Advancing HIV Prevention Research in Pregnant and Lactating People (PLP): Think
Tank Report & Action Plan identifies priority goals to advance the
responsible study of HIV prevention in PLP, a population that must be better
served by the research enterprise. Realizing these goals requires sustained
multi-stakeholder collaboration, including a central role for advocates and
community voices at every stage.
The action plan includes calls for using a
reproductive justice framework to work collaboratively in advancing the
research agenda, implementing Good Participatory Practice in trials that center
PLP, greater resources to support ethics bodies and for the harmonization of
regulatory frameworks to support a research agenda for PLP. It is building on a
growing consensus and evidence that safe, inclusive and ethical research among
PLP is imperative.
It’s time to move from exclusion to fair inclusion. We hope you’ll join us in supporting this action plan. Reach out to AVAC to share information on relevant initiatives and stay tuned for opportunities to learn more and engage!
Best,
AVAC
Comments
Post a Comment